focus -WSS

focus

author：hotspot 2025-09-14 15:17:55 - browse：3

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious.

The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant Medtronic, both of which have made surgical systems to treat hypertension.

Data from an analysis of three randomized clinical trials of ReCor Medical’s device showed a modest decrease in blood pressure after two months compared to a control group that received a placebo procedure. Medtronic’s late-stage trial showed that renal denervation reduced hypertension when measuring blood pressure in the doctor’s office, but did not show a reduction in blood pressure when patients measured it at home over 24 hours. At-home blood pressure is considered the more accurate measure, as blood pressure levels tend to artificially rise with anxiety in the clinic. Neither study presented serious safety concerns.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Wikipedia

WSS

A clever new way to fix Medicaid and graduate medical education

The new shift in health care is toward less care

Will General Catalyst be the first of many hospital takeovers?

First medicine developed to treat MASH expected to be approved soon

The new shift in health care is toward less care

Medicare will require more price transparency from hospitals

hotspot

focus

hotspot

Medical records are filled with copy

Change Healthcare cyberattack prompts Medicare loan program

Alkermes shareholders re

NEJM study link tiny plastics in blood vessels to heart problems

Guidelines to prevent youth baseball injuries need more muscle

First medicine developed to treat MASH expected to be approved soon

Jerome Adams on the need for new antivirals for Covid

With psoriasis trial ahead, Alumis raises $259 million

Supreme Court strikes down use of affirmative action

More doctors should go into startup world

hotspot

HPV cancer vaccine study demonstrates efficacy

Diversify hospital leadership teams to protect BIPOC patient health

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Ambulance rides for just $100? Advisers want major billing fixes

Biotech incubator Curie.Bio graduates its first startup

Biotech incubator Curie.Bio graduates its first startup

focus

Wikipedia

hotspot

hotspot